Publications by authors named "J P Campos-Hernandez"
Prostate cancer (PCa) is the second most common cancer among men worldwide. The main screening tool remains the prostate-specific antigen (PSA), which shows significant limitations, including poor sensitivity/specificity. Therefore, establishing accurate non-invasive diagnostic biomarkers remains an unmet clinical need in PCa.
View Article and Find Full Text PDFArticle Synopsis
- Multiple myeloma (MM) is the second most prevalent blood cancer worldwide, traditionally viewed as aggressive and deadly.
- Recent advancements in treatment, such as proteasome inhibitors, monoclonal antibodies, immunomodulators, and corticosteroids, have improved patient outcomes significantly.
- Due to innovative combination therapies and ongoing research, there is growing optimism for future treatments, aiming to make MM more manageable and potentially curable.
Multi-Centre Study of Progression Factors and Intravesical Recurrence in Patients with Urothelial Carcinoma of the Upper Urinary Tract.
Diagnostics (Basel)
November 2024
Article Synopsis
- A study was conducted to analyze factors influencing disease progression and recurrence in patients with upper urinary tract urothelial carcinoma (UTUC) who underwent surgery between 2015 and 2021.
- The study involved 170 patients and found that around 32.9% experienced disease progression, with key risk factors identified as pT stage, margin involvement, and lymphovascular involvement.
- Additionally, about 25.9% of patients had intravesical recurrence (IVR), significantly linked to a prior diagnosis of bladder cancer and the non-invasive appearance of tumors on CT scans.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organs and systems. It is characterized by the production of abnormal antibodies that attack healthy cells and tissues. The disease presents a wide range of symptoms and severity, from mild to severe.
View Article and Find Full Text PDFMagistral formulations emerged years ago and were of great help in the personalization of treatments for patients. Over time, innovation began in this area with new technologies such as three-dimensional (3D) printing, which has brought greater benefits, ease of preparation, new scopes, and even cost reduction. Three-dimensional printing of medicines opened the way to create personalized multi-dose, controlled-release, multi-drug tablets, among others.
View Article and Find Full Text PDF